These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20470846)

  • 21. Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment.
    Bouwman T; Cronin MT; Bessems JG; van de Sandt JJ
    Hum Exp Toxicol; 2008 Apr; 27(4):269-76. PubMed ID: 18684796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a read-across workflow for skin irritation and corrosion predictions.
    Abe A; Sezaki T; Kinoshita K
    SAR QSAR Environ Res; 2019 Apr; 30(4):279-298. PubMed ID: 31012352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory accepted but out of domain: In vitro skin irritation tests for agrochemical formulations.
    Kolle SN; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2017 Oct; 89():125-130. PubMed ID: 28734851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system.
    Gerner I; Zinke S; Graetschel G; Schlede E
    Altern Lab Anim; 2000; 28(5):665-98. PubMed ID: 11091765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The OSIRIS Weight of Evidence approach: ITS for skin sensitisation.
    Rorije E; Aldenberg T; Buist H; Kroese D; Schüürmann G
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):146-56. PubMed ID: 23792263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TIMES-SS--a mechanistic evaluation of an external validation study using reaction chemistry principles.
    Roberts DW; Patlewicz G; Dimitrov SD; Low LK; Aptula AO; Kern PS; Dimitrova GD; Comber MI; Phillips RD; Niemelä J; Madsen C; Wedebye EB; Bailey PT; Mekenyan OG
    Chem Res Toxicol; 2007 Sep; 20(9):1321-30. PubMed ID: 17713962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests.
    Kandárová H; Liebsch M; Genschow E; Gerner I; Traue D; Slawik B; Spielmann H
    ALTEX; 2004; 21(3):107-14. PubMed ID: 15329774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rat epidermal keratinocyte organotypic culture (ROC) as a model for chemically induced skin irritation testing.
    Pappinen S; Pasonen-Seppänen S; Suhonen M; Tammi R; Urtti A
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):233-41. PubMed ID: 16239167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity models for contact sensitization.
    Fedorowicz A; Singh H; Soderholm S; Demchuk E
    Chem Res Toxicol; 2005 Jun; 18(6):954-69. PubMed ID: 15962930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data.
    Jírová D; Basketter D; Liebsch M; Bendová H; Kejlová K; Marriott M; Kandárová H
    Contact Dermatitis; 2010 Feb; 62(2):109-16. PubMed ID: 20136894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
    Welss T; Basketter DA; Schröder KR
    Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simplified index to quantify the irritation/corrosion potential of chemicals - Part I: Skin.
    Charmeau-Genevois C; Sarang S; Perea M; Eadsforth C; Austin T; Thomas P
    Regul Toxicol Pharmacol; 2021 Jul; 123():104922. PubMed ID: 33819554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro irritation models and immune reactions.
    Gibbs S
    Skin Pharmacol Physiol; 2009; 22(2):103-13. PubMed ID: 19188758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential.
    Patlewicz G; Aptula AO; Uriarte E; Roberts DW; Kern PS; Gerberick GF; Kimber I; Dearman RJ; Ryan CA; Basketter DA
    SAR QSAR Environ Res; 2007; 18(5-6):515-41. PubMed ID: 17654336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro skin corrosion: Human skin model test - A validation study.
    Deshmukh GR; Kumar KH; Reddy PV; Rao BS
    Toxicol In Vitro; 2012 Sep; 26(6):1072-4. PubMed ID: 22542585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harmonization of thresholds for primary skin irritation from results of human repeated insult patch tests and laboratory animal skin irritation tests.
    Tardiff RG; Hubner RP; Graves CG
    J Appl Toxicol; 2003; 23(4):279-81. PubMed ID: 12884413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines.
    El Ghalbzouri A; Siamari R; Willemze R; Ponec M
    Toxicol In Vitro; 2008 Aug; 22(5):1311-20. PubMed ID: 18474418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis.
    Borlon C; Godard P; Eskes C; Hartung T; Zuang V; Toussaint O
    Toxicology; 2007 Nov; 241(3):157-66. PubMed ID: 17928126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Read-across to rank skin sensitization potential: subcategories for the Michael acceptor domain.
    Schultz TW; Rogers K; Aptula AO
    Contact Dermatitis; 2009 Jan; 60(1):21-31. PubMed ID: 19125718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. 1. Skin irritation.
    Fluhr JW; Darlenski R; Angelova-Fischer I; Tsankov N; Basketter D
    Skin Pharmacol Physiol; 2008; 21(3):124-35. PubMed ID: 18523410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.